Archive for June, 2016

Practical Law Guide to Orphan Drug Act (June 2016)

Legislative History The Orphan Drug Act, 21 U.S.C. § 360cc(a), was enacted in 1983 to foster the development of drugs—called orphan drugs—to treat rare diseases or conditions that affect fewer than 200,000 people.  These drugs were “orphaned,” because the comparatively small demand for treatment for any rare disease left pharmaceutical firms with little incentive to […]